Mechanotransduction in health and disease

Physical forces regulate cellular behaviour and function during all stages of life. Mechanotransduction, the process by which cells convert mechanical stimuli into biochemical signalling events is central to a number of physiological and pathological processes. The first part of this work focuses on...

Full description

Bibliographic Details
Main Author: Chronopoulos, Antonios
Other Authors: del Rio Hernandez, Armando
Published: Imperial College London 2017
Subjects:
Online Access:https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.733243
id ndltd-bl.uk-oai-ethos.bl.uk-733243
record_format oai_dc
spelling ndltd-bl.uk-oai-ethos.bl.uk-7332432019-03-05T15:35:06ZMechanotransduction in health and diseaseChronopoulos, Antoniosdel Rio Hernandez, Armando2017Physical forces regulate cellular behaviour and function during all stages of life. Mechanotransduction, the process by which cells convert mechanical stimuli into biochemical signalling events is central to a number of physiological and pathological processes. The first part of this work focuses on the effect of retinoid therapy on the mechanobiology of pancreatic cancer. Pancreatic cancer is characterised by a persistent activation of stromal fibroblasts, known as pancreatic stellate cells (PSCs), which can perturb the biomechanical homeostasis of the tumour microenvironment to favour tumour invasion. Using biophysical and biological techniques, we report that all-trans retinoic acid (ATRA), an active vitamin A metabolite restores mechanical quiescence in PSCs via a mechanism involving a retinoic acid receptor beta (RAR-β)-mediated downregulation of actomyosin (MLC-2) contracility. We show that ATRA reduces the ability of PSCs to generate high traction forces and adapt to extracellular mechanical cues (mechanosensing), as well as suppresses force-mediated extracellular matrix remodelling to inhibit local cancer cell invasion in 3D organotypic models. We thus suggest that ATRA may serve as a stroma reprogramming agent for the treatment of pancreatic cancer. In the second part of this work, we focus on syndecan-4 (Syn-4) - a ubiquitous transmembrane proteoglycan receptor. We identify Syn-4 as a cellular mechanotransducer that tunes cell mechanics by eliciting a global mechanosignalling response. We outline a mechanotransduction model whereby localised tension on Syn-4 triggers a synergistic cell-wide activation of β1 integrins, in a PI3K-dependent manner, to subsequently activate the RhoA pathway and induce adaptive cell stiffening. Furthermore, syndecan-4 mediated mechanosensing is required for YAP activation and downstream changes in gene expression. We propose that this newly identified mechanotransductive ability of Syn-4 should have direct implications for the field of mechanobiology.660.6Imperial College Londonhttps://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.733243http://hdl.handle.net/10044/1/56622Electronic Thesis or Dissertation
collection NDLTD
sources NDLTD
topic 660.6
spellingShingle 660.6
Chronopoulos, Antonios
Mechanotransduction in health and disease
description Physical forces regulate cellular behaviour and function during all stages of life. Mechanotransduction, the process by which cells convert mechanical stimuli into biochemical signalling events is central to a number of physiological and pathological processes. The first part of this work focuses on the effect of retinoid therapy on the mechanobiology of pancreatic cancer. Pancreatic cancer is characterised by a persistent activation of stromal fibroblasts, known as pancreatic stellate cells (PSCs), which can perturb the biomechanical homeostasis of the tumour microenvironment to favour tumour invasion. Using biophysical and biological techniques, we report that all-trans retinoic acid (ATRA), an active vitamin A metabolite restores mechanical quiescence in PSCs via a mechanism involving a retinoic acid receptor beta (RAR-β)-mediated downregulation of actomyosin (MLC-2) contracility. We show that ATRA reduces the ability of PSCs to generate high traction forces and adapt to extracellular mechanical cues (mechanosensing), as well as suppresses force-mediated extracellular matrix remodelling to inhibit local cancer cell invasion in 3D organotypic models. We thus suggest that ATRA may serve as a stroma reprogramming agent for the treatment of pancreatic cancer. In the second part of this work, we focus on syndecan-4 (Syn-4) - a ubiquitous transmembrane proteoglycan receptor. We identify Syn-4 as a cellular mechanotransducer that tunes cell mechanics by eliciting a global mechanosignalling response. We outline a mechanotransduction model whereby localised tension on Syn-4 triggers a synergistic cell-wide activation of β1 integrins, in a PI3K-dependent manner, to subsequently activate the RhoA pathway and induce adaptive cell stiffening. Furthermore, syndecan-4 mediated mechanosensing is required for YAP activation and downstream changes in gene expression. We propose that this newly identified mechanotransductive ability of Syn-4 should have direct implications for the field of mechanobiology.
author2 del Rio Hernandez, Armando
author_facet del Rio Hernandez, Armando
Chronopoulos, Antonios
author Chronopoulos, Antonios
author_sort Chronopoulos, Antonios
title Mechanotransduction in health and disease
title_short Mechanotransduction in health and disease
title_full Mechanotransduction in health and disease
title_fullStr Mechanotransduction in health and disease
title_full_unstemmed Mechanotransduction in health and disease
title_sort mechanotransduction in health and disease
publisher Imperial College London
publishDate 2017
url https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.733243
work_keys_str_mv AT chronopoulosantonios mechanotransductioninhealthanddisease
_version_ 1718994772680507392